Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2012-11-06 | New | $28,000,000 | $28,000,000 | Equity Only | 06 | SEC link |
| 2011-08-08 | New | $1,100,000 | $1,100,000 | Equity Only | 06 | SEC link |
| 2010-04-23 | New | $10,062,500 | $10,062,500 | Debt Only | 06 | SEC link |
| 2008-07-21 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2006-09-07 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Armando Anido | Director, Executive |
| Michael Cola | Director |
| Jeanne Cunicelli | Director |
| James A. Datin | Director |
| Michael C. Diem | Director |
| John H. Dillon, Ii | Director |
| Bart J. Dunn | Executive |
| William J. Federici | Director |
| Ezra H. Felker | Executive |
| Keith A. Goldan | Executive |
| Suzanne M. Hanlon | Executive |
| Jane H. Hollingsworth | Director, Executive |
| Richard S. Kollender | Director |
| Gary J. Kurtzman | Director |
| Michael F. Marino | Executive |
| Gerald W. Mc Laughlin | Executive |
| Robert P. Roche | Director |
| Terri B. Sebree | Executive |
| Brian J. Sisko | Director |
| Wayne P. Yetter | Director |